Unlock measurable value at every stage of the clinical development and commercialization journey.
Our end-to-end solution that sets a new standard in patient access.
Bringing together disparate, fragmented data to reveal fresh insights and produce predictive models, InConcert™ helps health and life sciences companies deliver sharper, more successful product launches.
The road to a successful product launch is a complex one, requiring a clear strategy and close collaboration between different functions. As you get closer to launch readiness, the demands on your teams come thick and fast, pressure mounts, and each decision can feel more critical than the last.
Making the right choices at the right time to ensure a successful launch comes down to how well you’re informed on several fronts. But getting a clear picture of everything you need, from clinical and market insights to HCP needs and behaviors, can be hugely challenging – particularly when the data is often disconnected and difficult to access.
InConcert™ tackles that problem head on. Seamlessly bringing together different datasets to reveal hidden insights and model different scenarios, InConcert™ helps you launch your product with confidence.
Listen to Jamie Avallone, Chief Data Officer at Inizio Evoke, explain how InConcert™ can help you not just get ready for launch, but ensure success goes far beyond day one.
A lot of healthcare solution providers start with the tech and look to win clients based on the sophistication of their product. At Inizio, we take a different approach. We always start with the real-world challenges you face and then tailor the solution to help you address them in a faster, smarter way.
With InConcert™, we bring together your existing data with carefully selected data from our proprietary data lake to create powerful, actionable insights you won’t find anywhere else.
Our data layers include:
Hear from Jamie again as he highlights the data driving InConcert™ and how it helps our clients.
Large Language Models (LLMs) such as ChatGPT, Google Gemini, and Claude are transforming the way humans interact with technology, from answering questions and analyzing complex data to automating tasks and generating content.
But while these off-the-shelf LLMs are highly useful for many general business tasks, they’re unable to convey the valuable HCP or patient insights life sciences teams are looking for when preparing their product for launch.
InConcert™ is different because its models and outputs are trained on specific data collected by Inizio, which is unavailable in the public domain. ChatGPT can’t tell you what product messages a certain type of doctor working in a particular community will best respond to, but – as Jamie explains – InConcert™ will.
InConcert™ is just one part of a unified framework of platforms, products, and solutions that enable Intelligent Commercialization™ by delivering scalable, data-driven impact at every stage of the healthcare journey.
Find out more about InConcert™ and Intelligent Commercialization™, and get in touch with our team to discuss how they can help make your next product launch the measurable success you’re looking for.
Jump to a slide with the slide dots.
The latest edition of PME has landed, and it features insights from experts across Inizio.
Read more
Offering realistic scenarios and credible HCP avatars, AI helps close the gap between training and the real-world demands faced by field teams.
Read more
Discover how teams from across Inizio provided a range of integrated services to give a client’s product the best chance of launch success.
Read more
From AI and data strategy to patient engagement and launch execution, here are five key takeaways from Reuters Pharma USA 2026.
Read more
PM360's latest Think Tank article highlights key elements for commercializing successful startups, with key insights from Mary-Kate McGarry.
Read more
